Gene plays key role in slowing melanoma growth

Share this content:
Increased levels of a certain gene can help decrease melanoma cell growth, according to a study published in the American Journal of Pathology (2010 May;176(5):2520-9).

According to background information provided in the press release announcing the study, melanoma is one of the least common forms of skin cancer yet causes 75% of skin cancer deaths.

In the study led by Victor Tron, MD, head of pathology and molecular medicine at Queen's University, researchers focused on MicroRNA 193b (miR-193b), a little-known gene found in DNA, discovered to be deficient in melanoma tumors. Through lab experiments with tissue samples, researchers reported that miR-193b played a role in the melanoma process.

Results of the experiments revealed that adding miR-193b to melanoma cells led to lower levels of the protein cyclin D1 and decreased melanoma cell growth. “Our experiment was a bit of a fishing expedition in the beginning. We thought 193b might be important but the fact we got such a tremendous reaction – the melanoma really slowed down when we added 193b – was really startling,” said Dr. Tron. “This is the first step in a long road towards finding a melanoma cure.”

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs